AbbVie Inc v. Brent

Court

District Court, E.D. Virginia (E.D. Va.)
Official Court Website →

Assigned judge

Claude M. Hilton · 4,773 cases in index

Docket number

1:24-cv-02344

Cause

35:154 AIA Appeal of Patent Term Adjustment Determination
35 U.S.C. § 154

Nature of suit

830 Patent
Infringement of a patented invention.

Jurisdiction

U.S. Government Defendant

Jury demand

None

Date filed

12/23/2024

Date terminated

07/29/2025

1,757 Patent cases in this court are indexed here.

Parties

• plaintiff · AbbVie, Inc Pharmaceuticals & Biotechnology · 5032 cases
• defendant · Brent · 159 cases

About Patent Lawsuits

Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.

Frequently Asked Questions

What is AbbVie Inc v. Brent?

AbbVie Inc v. Brent is a federal patent lawsuit filed on 12/23/2024 in the District Court, E.D. Virginia. The case was terminated on 07/29/2025. Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.

What type of case is this?

It is classified as “Patent” under the federal nature-of-suit system. Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.

What court is the case in?

The case is in the District Court, E.D. Virginia, docket number 1:24-cv-02344.

When was the case filed?

AbbVie Inc v. Brent was filed on 12/23/2024. It was terminated on 07/29/2025.

What law is the case brought under?

The docket lists the cause as 35 U.S.C. § 154.